Λίστα αντικειμένων
We discussed the central role of B cell activation in chronic GVHD and
discussed the results of ibrutinib in cGVHD which led to FDA approval.
Presenter: Prof. Spyridonidis
Participants. Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris